Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mol Biol Rep ; 40(7): 4625-35, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23653001

RESUMEN

Evidence indicates CCND1 G870A polymorphisms as a risk factor for a number of cancers. Increasing studies have been conducted on the association of CCND1 G870A polymorphism with lung cancer risk. However, the results were controversial. The aim of the present study was to derive a more precise estimation of the relationship. Meta-analyses examining the association between CCND1 G870A polymorphism and lung cancer were performed. Subgroup analyses regarding ethnicity, smoking status, histological types and source of controls were also implemented. All eligible studies for the period up to May 2012 were identified. The overall data from ten case-control studies including 5,008 cases and 5,214 controls indicated that variant A allele may have an association with increased lung cancer risk (AA vs GG: OR = 1.21; 95 % CI = 1.08-1.36, dominant model: OR = 1.09; 95 % CI = 1.00-1.19, recessive model: OR = 1.23; 95 % CI = 1.01-1.49). In the subgroup analysis by ethnicity, A allele may elevate lung cancer risk among Asians but not Caucasians or Mixed ethnicities. In smoking status subgroup, A allele was shown to associate with increased lung cancer risk among smokers but not non-smokers. In the subgroup analysis by histological types, increased cancer risks were shown in adenocarcinoma but not squamous cell carcinoma, under the homozygote comparison and recessive models. Collectively, the results of the present study suggest that CCND1 G870A polymorphism might be a low-penetrant risk factor for lung cancer, particularly among Asians and smokers. Moreover, homozygous AA alleles might have a correlation with increased lung adenocarcinoma susceptibility.


Asunto(s)
Ciclina D1/genética , Neoplasias Pulmonares/etiología , Polimorfismo Genético , Fumar , Alelos , Estudios de Casos y Controles , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Neoplasias Pulmonares/genética , Oportunidad Relativa , Sesgo de Publicación , Riesgo
2.
Eur Spine J ; 20 Suppl 2: S326-9, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21424915

RESUMEN

Intradural lumbar disc herniation is a rare complication of disc disease. The reason for the tearing of the dura matter by a herniated disc is not clearly known. Intradural disc herniations usually occur at the disc levels and are often seen at L4-L5 level but have also been reported at other intervertebral disc levels. However, intradural disc herniation at mid-vertebral levels is rare in the literature and mimics an intradural extramedullary spinal tumor lesion in radiological evaluation. Although magnetic resonance imaging (MRI) with gadolinium is useful in the diagnosis of this condition, preoperative correct diagnosis is usually difficult and the definitive diagnosis must be made during surgery. We describe here a 50-year-old female patient who presented with pain in the lower back for 6 months and a sudden exacerbation of the pain that spread to the left leg as well as numbness in both legs for 2 weeks. MRI demonstrated an intradural mass at the level of L5. Laminectomy was performed, and subsequently durotomy was also performed. An intradural disc fragment was found and completely removed. The patient recovered fully in 3 months. Intradural lumbar disc herniation must be considered in the differential diagnosis of mass lesions in the spinal canal.


Asunto(s)
Desplazamiento del Disco Intervertebral/diagnóstico por imagen , Disco Intervertebral/diagnóstico por imagen , Vértebras Lumbares/diagnóstico por imagen , Neoplasias de la Columna Vertebral/diagnóstico por imagen , Diagnóstico Diferencial , Femenino , Humanos , Disco Intervertebral/cirugía , Desplazamiento del Disco Intervertebral/cirugía , Laminectomía , Vértebras Lumbares/cirugía , Persona de Mediana Edad , Radiografía , Neoplasias de la Columna Vertebral/cirugía
3.
Dev Biol ; 309(2): 193-207, 2007 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-17698055

RESUMEN

TGFbeta3 signaling initiates and completes sequential phases of cellular differentiation that is required for complete disintegration of the palatal medial edge seam, that progresses between 14 and 17 embryonic days in the murine system, which is necessary in establishing confluence of the palatal stroma. Understanding the cellular mechanism of palatal MES disintegration in response to TGFbeta3 signaling will result in new approaches to defining the causes of cleft palate and other facial clefts that may result from failure of seam disintegration. We have isolated MES primary cells to study the details of MES disintegration mechanism by TGFbeta3 during palate development using several biochemical and genetic approaches. Our results demonstrate a novel mechanism of MES disintegration where MES, independently yet sequentially, undergoes cell cycle arrest, cell migration and apoptosis to generate immaculate palatal confluency during palatogenesis in response to robust TGFbeta3 signaling. The results contribute to a missing fundamental element to our base knowledge of the diverse roles of TGFbeta3 in functional and morphological changes that MES undergo during palatal seam disintegration. We believe that our findings will lead to more effective treatment of facial clefting.


Asunto(s)
Apoptosis/fisiología , Cadherinas/metabolismo , Ciclo Celular/fisiología , Hueso Paladar/citología , Factor de Crecimiento Transformador beta3/fisiología , Animales , Movimiento Celular/fisiología , Células Cultivadas , Células Epiteliales/citología , Células Epiteliales/metabolismo , Femenino , Masculino , Ratones , Hueso Paladar/embriología , Hueso Paladar/metabolismo , Embarazo , Transducción de Señal
4.
J Cell Sci ; 120(Pt 9): 1646-53, 2007 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-17452626

RESUMEN

Dissociation of medial-edge epithelium (MEE) during palate development is essential for mediating correct craniofacial morphogenesis. This phenomenon is initiated by TGFbeta3 upon adherence of opposing palatal shelves, because loss of E-cadherin causes the MEE seam to break into small epithelial islands. To investigate the molecular mechanisms that cause this E-cadherin loss, we isolated and cultured murine embryonic primary MEE cells from adhered or non-adhered palates. Here, we provide the first evidence that lymphoid enhancer factor 1 (LEF1), when functionally activated by phosphorylated Smad2 (Smad2-P) and Smad4 (rather than beta-catenin), binds with the promoter of the E-cadherin gene to repress its transcription in response to TGFbeta3 signaling. Furthermore, we found that TGFbeta3 signaling stimulates epithelial-mesenchymal transformation (EMT) and cell migration in these cells. LEF1 and Smad4 were found to be necessary for up-regulation of the mesenchymal markers vimentin and fibronectin, independently of beta-catenin. We proved that TGFbeta3 signaling induces EMT in MEE cells by forming activated transcription complexes of Smad2-P, Smad4 and LEF1 that directly inhibit E-cadherin gene expression.


Asunto(s)
Cadherinas/metabolismo , Células Epiteliales/metabolismo , Hueso Paladar/metabolismo , Factor de Crecimiento Transformador beta3/farmacología , Animales , Sitios de Unión/genética , Cadherinas/genética , Movimiento Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Células Cultivadas , Inmunoprecipitación de Cromatina , Citoplasma/metabolismo , Células Epiteliales/efectos de los fármacos , Fibronectinas/metabolismo , Expresión Génica/efectos de los fármacos , Immunoblotting , Luciferasas/genética , Luciferasas/metabolismo , Factor de Unión 1 al Potenciador Linfoide/genética , Factor de Unión 1 al Potenciador Linfoide/metabolismo , Ratones , Ratones Endogámicos , Mutación , Hueso Paladar/citología , Hueso Paladar/embriología , Unión Proteica , Proteína Smad2/genética , Proteína Smad2/metabolismo , Proteína Smad4/genética , Proteína Smad4/metabolismo , Transfección , Factor de Crecimiento Transformador beta3/genética , Factor de Crecimiento Transformador beta3/metabolismo , Vimentina/metabolismo , beta Catenina/genética , beta Catenina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA